Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Pharmacology: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

4 questions · 2 sources

Mechanism

How does TRODELVY work (mechanism of action)?

Pharmacokinetics

How is TRODELVY metabolized?

What is the half-life of TRODELVY?

Components

What are the ingredients in TRODELVY?